PMVP Earnings & Financial Statements
PMV Pharmaceuticals, Inc.
$1.24
-$0.11(-8.15%)
44
Overall
60
Value
58
Tech
15
Quality
Market Cap
$93.64M
Volume
525.84K
52W Range
$1.02 - $1.91
Target Price
$4.20
PMVP earnings and financial statements: PMV Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
PMVP Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$86.21M | -$85.45M | -$80.13M | -$77.04M | -$58.29M |
| EBITDA | -$86.12M | -$84.32M | -$78.87M | -$76.64M | -$57.99M |
| Net income | -$77.74M | -$58.71M | -$68.96M | -$73.32M | -$57.85M |
| EPS (diluted) | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $116.56M | $191.29M | $252.15M | $270.31M | $331.57M |
| Total liabilities | $11.85M | $15.21M | $26.46M | $24.28M | $23.01M |
| Shareholders’ equity | $104.71M | $176.08M | $225.69M | $246.03M | $308.56M |
| Cash and equivalents | $37.98M | $40.88M | $37.71M | $108.30M | $172.47M |
| Long-term debt | $435.0K | $838.0K | $12.43M | $13.45M | $10.79M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$73.58M | -$51.28M | -$55.66M | -$63.76M | -$46.57M |
| Capital expenditure | $2.0K | -$404.0K | -$962.0K | -$7.98M | -$1.35M |
| Free cash flow | -$73.61M | -$51.94M | -$56.62M | -$71.74M | -$47.92M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PMVP | $1.24 | -8.1% | 525.84K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get PMV Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW